Class IIOngoingD-0040-2027
Drug recall · October 21, 2026
Tirzepatide/Niacinamide 2mL vial recall
Why: Lack of assurance of sterility.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Tirzepatide/Niacinamide 2mL vial (40 MG per Vial) Inj 20mg/2mg/mL, RX Only, Houston RX LLC, 15430 Vantage Parkway E STE 220, Houston, TX 77032.
- Lots / codes
Lot# TZN-080326-20/2-2, Beyond Use Date: 12/01/2026.
- Quantity
- 64 vials
- Company
- Houston Rx LLC, Houston, TX
- Distribution
- Nationwide in the USA.
- Initiated
- September 25, 2026 · Voluntary: Firm initiated
- Classified
- October 13, 2026
- Reported
- October 21, 2026
- How notified
- Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.